The main people being hurt are the patients that need the drugs and the doctors that help those patients. Also the hospitals are being hit hard as well and trying to find some kind of discount for the higher prices.
Main Price Gougers in the Prescription Drug Industry:
One of the most notable is Martin Shkreli who was recently arrested for fraud in 2015 according to an article in the New York Times. Julie Creswell, Stephanie Clifford and Andrew Pollack (2015) wrote, “Shkreli has emerged as a symbol of pharmaceutical greed for acquiring a decades-old drug used to treat an infection that can be devastating for babies and people with AIDS and, overnight, raising the price to $750 a pill from $13.50. His only mistake, he later conceded, was not …show more content…
Here’s some examples according to (Brad Dixon of WSWS), “Glumetza (2015), a treatment for diabetes, went from $896 in 2013 to $10,020 in 2015 (an increase of 1016 percent). Isuprel (2015), a treatment for slow or irregular heart rate, went from $4,489 in 2013 to $36,811 in 2015 (an increase of 720 percent).”
This right here is a prime example of who is getting hurt and how by the price hikes. According to Andrew Pollack and Sabrina Tavernise of The New York Times (2015) wrote, “Mr. Mannes has been taking the same drug, Cuprimine, for 55 years to treat Wilson disease, an inherited disorder that can cause severe liver and nerve damage. This summer, Valeant more than quadrupled its price overnight.”(Pg.1/3)
This part here leads you to wonder what some people up in high places are thinking. If they keep increasing prices people might chance dying over paying a huge increase in price on their drugs they need. They further wrote, “Medicare will now have to cover about $35,000 for the 120 capsules he takes each month, and he will have to pay about $1,800 a month out of pocket, compared with about $366 he paid in May.”
Main Price Gougers in the Prescription Drug Industry:
One of the most notable is Martin Shkreli who was recently arrested for fraud in 2015 according to an article in the New York Times. Julie Creswell, Stephanie Clifford and Andrew Pollack (2015) wrote, “Shkreli has emerged as a symbol of pharmaceutical greed for acquiring a decades-old drug used to treat an infection that can be devastating for babies and people with AIDS and, overnight, raising the price to $750 a pill from $13.50. His only mistake, he later conceded, was not …show more content…
Here’s some examples according to (Brad Dixon of WSWS), “Glumetza (2015), a treatment for diabetes, went from $896 in 2013 to $10,020 in 2015 (an increase of 1016 percent). Isuprel (2015), a treatment for slow or irregular heart rate, went from $4,489 in 2013 to $36,811 in 2015 (an increase of 720 percent).”
This right here is a prime example of who is getting hurt and how by the price hikes. According to Andrew Pollack and Sabrina Tavernise of The New York Times (2015) wrote, “Mr. Mannes has been taking the same drug, Cuprimine, for 55 years to treat Wilson disease, an inherited disorder that can cause severe liver and nerve damage. This summer, Valeant more than quadrupled its price overnight.”(Pg.1/3)
This part here leads you to wonder what some people up in high places are thinking. If they keep increasing prices people might chance dying over paying a huge increase in price on their drugs they need. They further wrote, “Medicare will now have to cover about $35,000 for the 120 capsules he takes each month, and he will have to pay about $1,800 a month out of pocket, compared with about $366 he paid in May.”